NASDAQ:PLYX Polaryx Therapeutics Q3 2026 Earnings Results & Report $1.55 -0.06 (-3.73%) As of 02:47 PM Eastern This is a fair market value price provided by Massive. Learn more. Polaryx Therapeutics missed analyst earnings expectations in its Q3 2026 results, released November 12, 2026. The company reported EPS of -$0.07 versus the -$0.05 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 12, 2026TimeAfter Market ClosesConference Call7:00 AM ET Polaryx Therapeutics EPS ResultsActual EPS-$0.07Consensus EPS -$0.05Beat/MissMissed by -$0.02One Year Ago EPSN/APolaryx Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Polaryx Therapeutics Q3 2026 Earnings FAQ Did Polaryx Therapeutics beat earnings estimates for Q3 2026? Polaryx Therapeutics (NASDAQ:PLYX) reported earnings of -$0.07 per share for Q3 2026, missing the consensus estimate of -$0.05. The report was announced on Thursday, November 12, 2026. Polaryx Therapeutics Earnings HeadlinesHC Wainwright Issues Optimistic Forecast for PLYX EarningsNovember 14, 2026 | americanbankingnews.comPolaryx Activates First Site For Phase 2 SOTERIA Trial Of PLX-200November 9, 2026 | rttnews.comCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.November 19 at 1:00 AM | Decentralized Masters (Ad)Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200November 9, 2026 | globenewswire.comPolaryx Therapeutics Appoints New Chief Medical OfficerSeptember 1, 2026 | tipranks.comPolaryx Appoints Charlton As CMO; PLX-200 Set For Phase 2 In Q4 '26September 1, 2026 | rttnews.comSee More Polaryx Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Polaryx Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Polaryx Therapeutics and other key companies, straight to your email. Email Address About Polaryx TherapeuticsPolaryx Therapeutics (NASDAQ:PLYX) is a biotechnology company focused on developing treatments for rare genetic diseases. Its research and development activities target conditions with significant unmet medical needs, including disorders that affect the nervous system and metabolism. The company’s work centers on advancing drug candidates for these conditions. Publicly available information about its specific products, commercial operations, geographic reach and leadership is limited.View Polaryx Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.